Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic

Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

The market comprises of products, which are available in reusable and disposable form. Disposable segment is expected to witness growth, owing to significant increase in self-administration of drugs to treat chronic diseases. Moreover, the shift from vial-and-syringe format, which is prone to dosing errors and low patient-compliance rates to prefilled syringes that enable the use of disposable and single-use syringes already filled with a prescribed unit dose of medication, is expected to enhance the market growth.

Market Dynamics

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, higher cost of auto-injectors and product recalls are factors expected to restrain the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global subcutaneous drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
  • Global Subcutaneous Drug Delivery Market, By Usability:
  • Disposable
  • Reusable
  • Global Subcutaneous Drug Delivery Market, By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • Global Subcutaneous Drug Delivery Market, By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • Global Subcutaneous Drug Delivery Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Subcutaneous Drug Delivery Market, By Region:
  • North America
  • By Usability:
  • Disposable
  • Reusable
  • By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Usability:
  • Disposable
  • Reusable
  • By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Usability:
  • Disposable
  • Reusable
  • By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Usability:
  • Disposable
  • Reusable
  • By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Usability:
  • Disposable
  • Reusable
  • By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country/Region:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Usability:
  • Disposable
  • Reusable
  • By Disease Indication:
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
  • By Delivery Type:
  • Prefilled Syringe
  • Injector
  • Prefilled Pen
  • Vial (Syringe)
  • Pump and Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Becton, Dickinson and Company*
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Novo Nordisk A/S
  • Johnson & Johnson
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • F. Hoffmann-La Roche AG
  • Consort Medical plc
  • Eli Lilly and Company
  • Merck & Co., Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Usability
Market Snippet, By Disease Indication
Market Snippet, By Delivery Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Reimbursement Scenario
Merger and Acquisition Scenario
PEST Analysis
Epidemiology
4. Global Subcutaneous Drug Delivery Market, By Usability, 2016 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Disposable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Reusable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
5. Global Subcutaneous Drug Delivery Market, By Disease Indication, 2016 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Auto-immune Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Oncology Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Hormonal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Allergy & Infectious Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Ophthalmic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
6. Global Subcutaneous Drug Delivery Market, By Delivery System, 2016 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Prefilled Syringe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Injector
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Prefilled Pen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Vial (Syringe)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Pump and Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
7. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2016 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
8. Global Subcutaneous Drug Delivery Market, By Region, 2016 – 2026, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2016 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
South Africa
Central Africa
North Africa
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Becton Dickinson and Company*
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novo Nordisk A/S
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Amgen, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
F. Hoffmann-La Roche AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Consort Medical plc
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Eli Lilly and Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
10. Section
References
Research Methodology
About Us and Sales Contact
*Browse 36 market data tables and 30 figures on "Subcutaneous Drug Delivery Market” - Global forecast to 2026.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook